MarketPeel
Insider Trading Intelligence
OL

Olivier Loeillot

RGEN
CHIEF EXECUTIVE OFFICER · REPLIGEN CORP · CIK 0001995525
FILING MIX · LIFETIME56%/44%
BUYS
10
SELLS
8
TOTAL VALUE
$2.61M
COMPANIES
1
ACTIVE SINCE
Oct 2023
HOLDINGS NOW
54,246
AVG SELL PX
$146.82
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by Olivier Loeillot, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-7.72%+1.02%-8.74%-8.74%
14d2+100.00%-5.90%+1.99%-7.89%-7.89%
30d2+100.00%-10.89%+2.27%-5.83%-5.83%
60d2+100.00%-3.00%+4.08%-7.08%-7.08%
90d2(1 pending)+100.00%-21.17%+1.09%-22.26%-22.26%
180d2(1 pending)+100.00%-33.92%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RGEN · 54,246 shares · as of Apr 21, 2026
014,52029,03943,55958,078202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 10 buys / 8 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
3,832$140.00$536.5K54,246Apr 21, 2026Apr 22, 2026View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
24,13458,078Mar 5, 2026Mar 23, 2026View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
25,89025,890Mar 5, 2026Mar 23, 2026View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,610$124.97$201.2K33,944Mar 2, 2026Mar 3, 2026View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
344$128.73$44.3K35,554Feb 27, 2026Mar 3, 2026View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
7,041$170.00$1.20M35,898Nov 25, 2025Nov 26, 2025View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,248$145.23$181.2K42,939Oct 2, 2025Oct 6, 2025View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,506$116.18$291.1K44,187Sep 3, 2025Sep 4, 2025View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
14,48046,693Mar 3, 2025Mar 4, 2025View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
13,62713,627Mar 3, 2025Mar 4, 2025View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
343$156.54$53.7K32,213Feb 27, 2025Feb 28, 2025View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
861$123.41$106.3K32,556Nov 20, 2024Nov 21, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
17,63133,417Sep 3, 2024Sep 4, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
16,27816,278Sep 3, 2024Sep 4, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
2,8602,860Feb 27, 2024Feb 29, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
2,88015,786Feb 27, 2024Feb 29, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
24,23624,236Oct 2, 2023Oct 3, 2023View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
12,90612,906Oct 2, 2023Oct 3, 2023View →
Other insiders · RGEN
Loading peer insiders…
About this filer
CIK 0001995525
ROLE
Chief Executive Officer
PRIMARY
RGEN
COMPANIES
1
ACTIVE SINCE
Oct 2023
MARKETPEEL · /INSIDER/0001995525DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback